Evolution of chronic antibody mediated-rejection: a case report.
Cornell
Lynn D
LD
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Wong
Waichi
W
Saidman
Susan
S
Collins
A Bernard
AB
Colvin
Robert B
RB
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001706:Biopsy; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D000069283:Rituximab